Optibiotix Health Share Discussion Threads

[f3rdinand] 05/9/2017 07:17

The coverage will indeed be very interesting- massive cholesterol reduction + healthy sugars + Tata = ???

[tony773] 05/9/2017 07:16

I see Opti down 6 can this be right???

[parob] 05/9/2017 07:15

So LPGOS has been shown in gut models to modify an individual's existing microbiome reducing cholesterol by up 22%.And also increase the growth and biological activity of OptiBiotix's cholesterol reducing strain (LP-LDL(R) ), leading to a threefold increase in the strains cholesterol lowering ability. We know this is up to 36.7% reduction in those with high LDL cholesterol.If I am reading the RNS correctly what kind of reduction are we looking at here then!!???Expect widespread media coverage with a brand like Tata on board.

[rafboy] 05/9/2017 07:14

Tipping point approaching fast.

[parob] 05/9/2017 06:42

Excellent!

[john henry] 05/9/2017 06:03

Very interesting F3, expect an RNS today. So the sweet fibre deals etc starting to roll out. Looks like the Times got heads up on the deal after hrs.

[f3rdinand] 05/9/2017 05:55

Opitbiotix biotech company signs sweet deal with Tata Chemicals

A biotechnology company developing products to tackle obesity, high cholesterol and diabetes has struck a manufacturing agreement with Tata Chemicals.

Under a deal set to be announced today, Optibiotix Health, the Aim-quoted company, has granted the rights to the Indian-listed food ingredients company, part of Tata Group, to produce a sugar from its cholesterol and blood pressure-lowering probiotic for use in food and over-the-counter products.

The agreement builds on a deal in December between the company and Tata Chemicals to develop weight loss products for the Indian market.

The deal with Tata Chemicals, which follows trials in November, is limited to India, but Optibiotix is in talks with other companies about manufacturing the sugar in markets, such as the US.

The financial terms of the deal are not expected to be disclosed, but Optibiotix is likely to receive royalty payments of 10 to 15 per cent. Stephen O’Hara, chief executive of Optibiotix, and its biggest shareholder with a near-13 per cent stake, said that the sugar could be utilised in snacks and baked products.


“We believe the combination of Optibiotix’s ability to develop ingredients which can modify an individual’s microbiome, and Tata’s research and manufacturing expertise, international reputation and global reach, places both companies at the forefront of global microbiome research and product development,” he said.

It caps a busy period for the company which spun off Skin Bio Therapeutics, a skincare company, in April on Aim.

The Aim listing helped to boost Optibiotix’s pre-tax profits to £3.1 million in the six months to the end of May, up from a loss £713,772 the year before.

Shares in Optibiotix closed down 3p at 71p before the deal was announced, valuing the company at £55.8 million.

[f3rdinand] 05/9/2017 05:47

Very interesting!!!!https://www.thetimes.co.uk/article/biotech-company-opitbiotix-signs-sweet-deal-with-tata-chemicals-2ght3qbkk

[shrewdmole] 04/9/2017 23:10

Not me

Here for the long term. This one is the golden egg.

[loungeact] 04/9/2017 22:38

SBTX Dr Catherine O’Neill mention. - PROBIOTICS MAY REPLACE ANTIBIOTICS IN THE FUTURE -

[trotterstrading] 04/9/2017 21:25

Good to see SBTX creeping up. Nicely poised now ahead of news, which much be imminent (trial plans and manufacturing scale up news). Given how little free float there is and the lock in period for 60%+ of share register it could really fly!

[affemoose] 04/9/2017 18:59

Thanks, will review.

[parob] 04/9/2017 18:47

Healthy ageing article by our very own Peter Wennström

Successes and Failures in Healthy Aging Product Launches

[riskybusiness1] 04/9/2017 16:09

https://www.probiotaevent.com/wp-content/uploads/2017/02/SCIENTIFIC-FRONTIERS-ABSTRACTS.pdfAffe - Above abstracts shown at probiota 2017. Number 4 & 12 are optis studies. Note these were done independently by reading university professor glen gibson world key opinion leader in this field. This should be published in a mainstream journal shortly.Slimbiome is made up of 3 ingredients: glucomannan, oligofructose and chromium piccolonate. These ingredients are sold separately and individually have many scientific claims. optis patent protects the unique combination of the ingredients. The oligofructose will be replaced with more targeted prebiotics in the future using optis optibiotic platform. People tend to view optis weigh management division as simply slimbiome but there's much more to come.

[rafboy] 04/9/2017 15:58

AffeMoose, have you looked at the OPTI website, read the RNS's going back along etc etc?

[ibug] 04/9/2017 15:52

SBTX is another SOH backed incubator project that is likely to make huge returns for investors who enter at current share price levels imo...low cash burn, high demand products once tested and approved.

[parob] 04/9/2017 14:55

SBTX breaking out...

[judijudi] 04/9/2017 14:26

Way over 80 Zebbo :)

[zebbo] 04/9/2017 13:32

Yep, they will be buying them back at 80...lol

[judijudi] 04/9/2017 13:17

Wonder who that is hey scotty?
:)

[f3rdinand] 04/9/2017 13:12

Probably the same person that was buying blocks in the 50's and 60's now taking a nice profit!

[judijudi] 04/9/2017 13:09

somebody really knocking them out today
fools